The reporting year was one of the most successful ever recorded by the Carl Zeiss Group – this is clearly underscored by both revenue and earnings. Revenue totaled EUR 4.163b; net annual income EUR 250m. Revenue increased by two percent over the adjusted previous year.
The Supervisory Board would like to thank the Executive Board, the employee representatives and all employees of Carl Zeiss for their dedication and commitment, which played a major role in the success achieved in fiscal year 2011/12.
Carl Zeiss is the market leader in lithography optics – the basic technology required for microchip production.
Medical systems from Carl Zeiss are used in ophthalmology, neurosurgery, and ear, nose and throat surgery.
Industrial measuring technology from Carl Zeiss ensures maximum standards of quality wherever high precision is a must.
Carl Zeiss stands for optimal visual comfort and is one of the world’s leading eyeglass lens manufacturers.